- American City Business Journals•10 days ago
Embattled drug giant Valeant Pharmaceuticals International (VRX) heard some much-needed good news when the U.S. Food and Drug Administration approved a drug that has deep roots in Raleigh. Specifically, FDA approved Relistor tablets for the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain. The drug was a legacy product of Salix Pharmaceuticals, the Raleigh pharmaceutical company Valeant acquired in 2015.
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|52wk Range||undefined - undefined|
|Day's Range||N/A - N/A|
|Avg Vol (3m)||N/A|